Full Press Release Details
Immutep Doses First Patient in AIPAC-003 Phase II/III Trial for Metastatic Breast Cancer.
IMMP
Immutep Doses First Patient in AIPAC-003 Phase II/III Trial for Metastatic Breast Cancer
Key Takeaway: Immutep Doses First Patient in AIPAC-003 Phase II/III Trial for Metastatic Breast Cancer